New stent aims to save legs from amputation in severe artery disease

NCT ID NCT03477604

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the MicroStent, a small mesh tube placed in leg arteries below the knee to keep them open. It involves 177 adults with severe peripheral artery disease who have pain at rest or non-healing sores. Half get the stent plus standard balloon treatment, the other half get balloon treatment alone. The goal is to see if the stent helps keep arteries open longer and prevents major complications like amputation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MicroStent (a self-expanding stent) used with standard balloon angioplasty

What this could lead to

If successful, this stent could offer a better way to keep arteries open below the knee, reducing the need for repeat procedures and lowering the risk of amputation in people with severe leg artery disease.

What could go wrong

This is a mid-stage trial with 177 participants, so results may not apply to everyone. Stents can fail due to re-blockage or movement, and the procedure carries risks like bleeding or infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

limb ischemia peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AMI Vascular Institute

    Galloway, New Jersey, 08205, United States

  • AZH/WAVE Vascular Center

    Milwaukee, Wisconsin, 53221, United States

  • Advanced Cardiac and Vascular Amputation Prevention Centers

    Grand Rapids, Michigan, 49525, United States

  • Advent Health Sebring

    Sebring, Florida, 33872, United States

  • Brown University

    Providence, Rhode Island, 02904, United States

  • Cardiology Consultants

    Spartanburg, South Carolina, 29303, United States

  • Cardiothoracic and Vascular Surgeons

    Austin, Texas, 78756, United States

  • Cardiovascular Associates of the Southeast

    Birmingham, Alabama, 35243, United States

  • Cardiovascular Institute of the South

    Houma, Louisiana, 70360, United States

  • Copper State Vascular

    Mesa, Arizona, 85203, United States

  • Deborah Heart and Lung Center

    Browns Mills, New Jersey, 08015, United States

  • FHV Health

    Leesburg, Florida, 34748, United States

  • First Coast Cardiovascular Institute

    Jacksonville, Florida, 32256, United States

  • Mount Sinai Medical Center

    Miami Beach, Florida, 33140, United States

  • North Jersey Vascular Center

    Clifton, New Jersey, 07013, United States

  • Palm Vascular

    Fort Lauderdale, Florida, 33312, United States

  • Rocky Mountain Regional VA Medical Center

    Aurora, Colorado, 80045, United States

  • St. Helena Hospital

    St. Helena, California, 94574, United States

  • US Cardiovascular

    Jefferson Hills, Pennsylvania, 15025, United States

  • University of Maryland - Baltimore

    Baltimore, Maryland, 21201, United States

  • Vascular Institute of the Midwest

    Davenport, Iowa, 52807, United States